314 Stock Overview
Operates as a medical technology and health management company in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 314 from our risk checks.
Sipai Health Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$5.60 |
| 52 Week High | HK$8.60 |
| 52 Week Low | HK$4.99 |
| Beta | 0 |
| 11 Month Change | 8.74% |
| 3 Month Change | -1.75% |
| 1 Year Change | -23.29% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -77.60% |
Recent News & Updates
Recent updates
Why We're Not Concerned About Sipai Health Technology Co., Ltd.'s (HKG:314) Share Price
Jun 08
Here's Why We're Not At All Concerned With Sipai Health Technology's (HKG:314) Cash Burn Situation
Feb 14Sipai Health Technology Co., Ltd.'s (HKG:314) 66% Price Boost Is Out Of Tune With Revenues
Apr 17Sipai Health Technology (HKG:314) Is In A Strong Position To Grow Its Business
Mar 24Shareholder Returns
| 314 | HK Consumer Retailing | HK Market | |
|---|---|---|---|
| 7D | 7.1% | -0.2% | 0.4% |
| 1Y | -23.3% | -28.0% | 12.0% |
Return vs Industry: 314 exceeded the Hong Kong Consumer Retailing industry which returned -28% over the past year.
Return vs Market: 314 underperformed the Hong Kong Market which returned 12% over the past year.
Price Volatility
| 314 volatility | |
|---|---|
| 314 Average Weekly Movement | 6.7% |
| Consumer Retailing Industry Average Movement | 8.0% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 18.9% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 314 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 314's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 3,250 | Xuguang Ma | www.medbankshealthtech.com |
Sipai Health Technology Co., Ltd. operates as a medical technology and health management company in the People’s Republic of China. The company operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Health Insurance Services Business. The Specialty Pharmacy Business segment operates specialty pharmacy stores; and distributes pharmaceutical products to pharmaceutical companies and other distributors.
Sipai Health Technology Co., Ltd. Fundamentals Summary
| 314 fundamental statistics | |
|---|---|
| Market cap | HK$4.28b |
| Earnings (TTM) | -HK$259.73m |
| Revenue (TTM) | HK$4.98b |
0.9x
P/S Ratio-16.5x
P/E RatioIs 314 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 314 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.64b |
| Cost of Revenue | CN¥4.21b |
| Gross Profit | CN¥423.29m |
| Other Expenses | CN¥664.94m |
| Earnings | -CN¥241.65m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.32 |
| Gross Margin | 9.13% |
| Net Profit Margin | -5.21% |
| Debt/Equity Ratio | 0% |
How did 314 perform over the long term?
See historical performance and comparison